JDD Issue Highlights | February 2022
The February 2022 issue of the Journal of Drugs in Dermatology (JDD) includes the perfect blend of original articles, case reports, and editorials. With topics ranging from psoriasis and actinic keratoses to artificial intelligence in dermatology and disparities in telemedicine satisfaction, we share this month’s issue highlights straight from the JDD Editor’s desk:
Early Response is Associ …
The February 2022 issue of the Journal of Drugs in Dermatology (JDD) includes the perfect blend of original articles, case reports, and editorials. With topics ranging from psoriasis and actinic keratoses to artificial intelligence in dermatology and disparities in telemedicine satisfaction, we share this month’s issue highlights straight from the JDD Editor’s desk:
Early Response is Associ …
Perniosis (also known as pernio or chilblains), is a condition characterized by the development of pruritic, painful erythrocyanotic skin lesions induced by exposure to cold temperatures.² When perniosis occurs in conjunction with clinical or laboratory features of systemic lupus erythematosus, the condition is further classified as chilblain lupus erythematosus (CHLE). CHLE is a rare condition w …
The Journal of Drugs in Dermatology kicks off 2022 with an outstanding line up of editorials, original articles, and case reports focusing on aesthetic treatments. Straight from the Editor’s desk, we share this month’s issue highlights:
Authors establish that the test device is non-inferior to the comparator in Safety and Effectiveness of a Novel Hyaluronic Acid Gel for Lip Augmentation.
…
Facial fillers are an increasingly popular cosmetic procedure used for facial rejuvenation. Regardless of the experience and skill level of the injector, fillers can inadvertently occlude vessels leading to blockage of cutaneous blood supply, ischemic skin necrosis and rarely cerebrovascular strokes and blindness. Injectors should recognize early signs of occlusion and be prepared with knowledge a …
Palmoplantar pustulosis (PPP) is a rare, recurrent skin disorder that presents a major challenge to clinical therapy. JDD author Danilo C. Del Campo, MD, FAAD reports a case of a 69-year-old woman with a 20-year history of psoriasis with skin manifestations and clinical and pathologic features consistent with PPP. After intolerance to apremilast and unsuccessful use of topical corticosteroids and …